Blood pressure drugs recalled over cancer concern (Source usatoday.com) A generic drug company has recalled three commonly prescribed blood pressure medications over concerns they could include small amounts of a cancer-causing impurity. The recalled drugs all include the blood-pressure medication valsartan, the subject of a series of recalls by several drug companies since July.

The generic drug company Mylan Pharmaceuticals recalled 104 lots of three medications: valsartan tablets, combination tablets with the drugs valsartan and amlodipine, and combination tablets with valsartan and hydrochlorothiazide.

Testing revealed that valsartan contained trace amounts of N-nitrosodiethylamine, or NDEA, a possible human carcinogen, the company said.

Amlodipine and hydrochlorothiazide in standalone form are not subject to the recall.